New committee aims to make Korea 'global bio leader' by 2035
Published: 23 Jan. 2025, 17:33
![A poster featuring the national bio committee's plan [YONHAP]](https://koreajoongangdaily.joins.com/data/photo/2025/01/23/514608a2-494e-43d2-bdeb-b69903dacbc9.jpg)
A poster featuring the national bio committee's plan [YONHAP]
The government established a national bio committee Thursday with an aim to make Korea one of five global leaders in the bio industry by 2035, the Science Ministry said.
The committee will devise a strategy to foster the bio industry as a future growth engine, according to the Ministry of Science and ICT.
The committee plans to create a 1 trillion won ($695.7 million) fund to promote private investment in the biopharmaceutical and vaccine industry.
It aims to expand the production capacity of contract development and manufacturing organizations (CDMO) by 2.5 to help Korea hit No. 1 in CDMO sales globally by 2032.
The committee will assist the country in independently developing about 15 percent of its core biomaterials, parts and equipment by 2030.
Additionally, the committee will work to innovate the research and development system of biopharma by reducing the time and cost of new drug development to half of the current requirement.
It will push for the integration of bio and other technologies, such as artificial intelligence and data science, to foster more innovation.
The committee plans to create a national bio data platform to secure 10 million units of data by 2035 and advanced computing infrastructure with at least 3,000 GPUs for bio research.
It will also create a consultative body of bio clusters in the country to promote cooperation between them and strengthen collaboration with foreign bio clusters.
The Science Ministry said the committee will also work to train 110,000 new professionals in the health industry by 2027.
Yonhap
with the Korea JoongAng Daily
To write comments, please log in to one of the accounts.
Standards Board Policy (0/250자)